Intra-Cellular Therapies

-$0.77 (-1.32%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITCI and other ETFs, options, and stocks.

About ITCI

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS.

CEO
Sharon Mates
Employees
512
Headquarters
New York, New York
Founded
2002

ITCI Key Statistics

Market cap
5.45B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.39M
High today
$60.64
Low today
$57.39
Open price
$58.50
Volume
930.84K
52 Week high
$66.00
52 Week low
$28.40

ITCI Earnings

-$1.05
-$0.92
-$0.78
-$0.65
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.92 per share
Actual
-$0.78 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure